MOVE Protocolâ„¢ â€“ Movement-Oriented Velocity of Engagement
Official Clinical Trial Repository (MOVE-001/2025)
NCT Registration: NCT07220200

This repository houses the complete scientific, methodological, and clinical documentation of the MOVE Protocolâ„¢, a multi-site, interventional clinical framework for acute and subacute musculoskeletal rehabilitation.

The MOVE-001/2025 trial has been fully completed, with all sites finalized and data locked.

ğŸ“Œ Clinical Trial Identification
Field	Details
Protocol ID	MOVE-001/2025
Version	1.0
Finalization Date	17 October 2025
Trial Status	Completed
Study Type	Prospective, Multi-Site, Interventional Case-Series
ClinicalTrials.gov	https://clinicaltrials.gov/study/NCT07220200

Sponsor	MMSx Authority Institute for Movement Mechanics & Biomechanics Research
Principal Investigator	Dr. Neeraj Mehta, PhD (Biomechanics & Alternative Medicine)
Contact	info@mmsxauthority.com
ğŸ“„ Official MOVE Protocol (Full PDF)

The full clinical protocol is available here:
â¡ï¸ MOVE-001/2025 Clinical Protocol (PDF)
(Uploaded in this repository under /docs)


Clinical Study Protocol_MOVE-00â€¦

ğŸ§¬ Scientific Framework: MOVEâ„¢ Pillars

From the validated clinical protocol:

M â€” Mobilize Early
Pain-free AROM, breath-led mobility, graded tissue glides.

O â€” Optimize Load
Isometric â†’ isotonic â†’ eccentric progression with structured RPE.

V â€” Validate Neural Control
Proprioception, balance, perturbation tasks, hop-prep.

E â€” Energize Recovery
Zone-2/3 cardio for systemic circulation and metabolic support.

Fully aligned to the mechanotherapy principles (Khan & Scott, BJSM 2009) and PEACE & LOVE guidelines (Dubois & Esculier, BJSM 2020).

ğŸ“Š Included Clinical Materials
1. Full Clinical Study Protocol

MOVE-001/2025 (25 pages): background, rationale, objectives, endpoints, statistical plan, ethics compliance.


Clinical Study Protocol_MOVE-00â€¦

2. Pain Trajectory Graphs (W0â€“W8)

See page 9 of the protocol:

Pain reduction from ~7 â†’ ~3 (mean Â± 95% CI).

3. Adverse Event Profile

(Page 14)

0 serious adverse events, excellent safety profile.

4. Functional Outcomes

(Page 24)

Improvements in SLS, STS, and Time-to-ADL ECDF.

5. SOPs, CRFs & Assessment Tools

(Page 25)

Informed consent template

CRF sample

Home program templates

Outcome measure SOPs

ğŸŒ Public Document Access

All MOVE Protocol files are also accessible at:

ğŸ”— www.mmsxauthority.com/MOVE2025_docs

ğŸ“¬ Contact

For research partnerships, verification documents, or institutional alignment:

ğŸ“© info@mmsxauthority.com

ğŸŒ www.mmsxauthority.com

Â© 2025 MMSx Authority Institute

MOVE Protocolâ„¢ is a proprietary clinical framework under the MMSx Authority Intellectual Property & Research Program. All rights reserved.
